Saturday, July 12, 2025

Latest

Organigram: Canaccord Reiterates $3.50 Target

On July 13th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fiscal third-quarter results. The company announced top-line revenue of $20.3 million, a 39% increase quarter over quarter and 13% year over year. The companies adult-use net revenue segment grew 40% over the last quarter to $16.8 million. The company had a negative gross margin before fair value adjustments of $3 million and had a net loss of $4 million.

Two analysts increased their 12-month price targets following earnings, bringing the 12-month average price target to C$3.93. The company has 14 analysts covering the stock, with the street high sitting at C$5.95 from Cantor Fitzgerald and the lowest comes in at C$2.50. Out of the 14 analysts, one analyst has a strong buy rating, two have buys, and the other 11 have hold ratings.

In Canaccord’s note on July 13th, they reiterate their C$3.50 price target and hold rating, saying that the top-line growth still didn’t move the needle towards profitability. The results generally came in below their estimates.

Below you can see Canaccord’s estimate versus the results. Canaccord estimated that revenue would come in at $19.8 million. They say that the increase was primarily due to “a normalization of ~C$7M of lost revenues in the prior quarter due to production and processing constraints.” COVID-19 headwinds and lower provincial demand however still damped the growth in the adult-use segment. Canaccord believes that the companies $22 million in cash on hand will be sufficient for all “near-to-medium-term operating losses and planned Capex spend.”

Below you can see Canaccord’s revised 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Alamos Gold Sees Canaccord Lift Rating To Buy After Q1 Results

This past week Alamos Gold Inc. (TSX: AGI) reported its first quarter financial results. The...

Saturday, April 30, 2022, 01:16:00 PM

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with...

Friday, June 17, 2022, 10:49:29 AM

Organigram Shares Slump On Q4 2023 Financials: Net Loss Widens By 437%

Organigram Holdings (TSX: OGI) saw a decline in its share price as the firm reported...

Tuesday, December 19, 2023, 09:41:35 AM

Enthusiast Gaming: Canaccord Updates Model Following Conference

Recently Canaccord Genuity sat down with Enthusiast Gaming’s (TSX: EGLX) C-suite to talk about the...

Friday, May 7, 2021, 03:17:00 PM

Tesla: Q1 Consensus Estimates

Tesla (NASDAQ: TSLA) will be reporting their first quarter financial results on April 26th after...

Sunday, April 25, 2021, 01:11:00 PM